Exhibit 99.1 SenesTech Announces 2023 Financial Results YTD 2024 total revenue up more than 80% compared to YTD 2023 driven by orders for EvolveTM soft bait PHOENIX, Ariz., February 21, 2024. SenesTech, Inc. (NASDAQ: SNES, “SenesTech” or the “Company”), the rodent fertility control experts and inventors of the only EPA-registered contraceptive for male and female rats, ContraPest®, today announced 2023 financial results. “During 2023, we executed on a number of key initiatives that will be the foundation to ...